European biotech startup Cradle raised $24 million, gaining funds for its effort to use AI to help scientists design and engineer proteins faster and more cost-effectively.
Index Ventures and Kindred Capital participated in the Series A round, along with Chris Gibson, the co-founder of Recursion Pharmaceuticals Inc., and Tom Glocer, the former chief executive officer of Thomson Reuters Corp. and a Merck & Co. board member, Cradle said Tuesday. The startup has raised a total of $33 million so far, including a seed round last year.
{Categories} Healthcare,_Category: Platforms,*ALL*{/Categories}
{URL}https://www.bloomberg.com/news/articles/2023-11-28/google-alum-s-ai-startup-raises-24-million-for-biotech-work{/URL}
{Author}Saritha Rai{/Author}
{Image}https://gumlet.assettype.com/bloombergquint%2F2023-11%2F1ca95b3d-c4a7-4aca-be7c-232455ce1228%2F_1x_1.jpg?rect=0%2C142%2C1999%2C1049&w=1200&auto=format%2Ccompress&ogImage=true{/Image}
{Keywords}Business,Technology,World,Bloomberg{/Keywords}
{Source}All{/Source}
{Thumb}{/Thumb}